Fungal
keratitis is a serious infectious keratopathy related to
fungal virulence and excessive inflammatory responses. Autophagy exhibits
a potent ability to resolve inflammation during fungal infection.
This study aimed to investigate the protective function of flavopiridol
in Aspergillus fumigatus keratitis
and explore its effects on autophagy. In our study, the corneas of
the fungal keratitis mouse model were treated with 5 μM flavopiridol. In vitro, RAW 264.7 cells were pretreated with 200 nM flavopiridol
before fungal stimulation. A. fumigatus was incubated with flavopiridol, and the antifungal activity of
flavopiridol was detected. Our results indicated that flavopiridol
treatment notably reduced clinical scores as well as cytokines expression
of infected corneas. In infected RAW 264.7 cells, flavopiridol treatment
inhibited IL-1β, IL-6, and TNF-α expression but promoted
IL-10 expression. Transmission electron microscopy (TEM) images showed
that more autolysosomes were present in infected corneas and RAW 264.7
cells after flavopiridol treatment. Flavopiridol treatment notably
upregulated the protein expression of LC3, Beclin-1, and Atg-7. 3-Methyladenine
(3-MA, an inhibitor of autophagy) pretreatment counteracted the cytokine
regulation induced by flavopiridol. Moreover, flavopiridol promoted
the phagocytosis of RAW 264.7 cells. Flavopiridol also exhibited antifungal
activity by restricting fungal growth and limiting fungal biofilm
formation and conidial adhesion. In conclusion, flavopiridol significantly
alleviated the inflammation of fungal keratitis by activating autophagy.
In addition, flavopiridol promoted the phagocytosis of RAW 264.7 cells
and exhibited antifungal function, indicating the potential therapeutic
role of flavopiridol in fungal keratitis.